Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Programmed Death-1 expression on Epstein Barr virus specific CD8+ T cells varies by stage of infection, epitope specificity, and T-cell receptor usage.

Greenough TC, Campellone SC, Brody R, Jain S, Sanchez-Merino V, Somasundaran M, Luzuriaga K.

PLoS One. 2010 Sep 23;5(9):e12926. doi: 10.1371/journal.pone.0012926.

2.

Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Sauce D, Larsen M, Abbott RJ, Hislop AD, Leese AM, Khan N, Papagno L, Freeman GJ, Rickinson AB.

J Virol. 2009 Sep;83(18):9068-78. doi: 10.1128/JVI.00141-09.

3.

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64.

4.

Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients.

Zhang Z, Jin B, Zhang JY, Xu B, Wang H, Shi M, Wherry EJ, Lau GK, Wang FS.

J Hepatol. 2009 Jun;50(6):1163-73. doi: 10.1016/j.jhep.2009.01.026.

PMID:
19395117
5.

Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential.

Dunne PJ, Faint JM, Gudgeon NH, Fletcher JM, Plunkett FJ, Soares MV, Hislop AD, Annels NE, Rickinson AB, Salmon M, Akbar AN.

Blood. 2002 Aug 1;100(3):933-40.

6.

Functional restoration of HCV-specific CD8 T cells by PD-1 blockade is defined by PD-1 expression and compartmentalization.

Nakamoto N, Kaplan DE, Coleclough J, Li Y, Valiga ME, Kaminski M, Shaked A, Olthoff K, Gostick E, Price DA, Freeman GJ, Wherry EJ, Chang KM.

Gastroenterology. 2008 Jun;134(7):1927-37, 1937.e1-2. doi: 10.1053/j.gastro.2008.02.033.

7.

Differential kinetics and specificity of EBV-specific CD4+ and CD8+ T cells during primary infection.

Precopio ML, Sullivan JL, Willard C, Somasundaran M, Luzuriaga K.

J Immunol. 2003 Mar 1;170(5):2590-8.

8.

Comparative immunophenotypic features of EBV-positive and EBV-negative atypical lymphocytosis.

Hudnall SD, Patel J, Schwab H, Martinez J.

Cytometry B Clin Cytom. 2003 Sep;55(1):22-8.

9.

The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8+ T-cell function.

Raziorrouh B, Schraut W, Gerlach T, Nowack D, Grüner NH, Ulsenheimer A, Zachoval R, Wächtler M, Spannagl M, Haas J, Diepolder HM, Jung MC.

Hepatology. 2010 Dec;52(6):1934-47. doi: 10.1002/hep.23936.

PMID:
21064032
10.

Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.

Velu V, Kannanganat S, Ibegbu C, Chennareddi L, Villinger F, Freeman GJ, Ahmed R, Amara RR.

J Virol. 2007 Jun;81(11):5819-28.

11.

The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection.

Plunkett FJ, Soares MV, Annels N, Hislop A, Ivory K, Lowdell M, Salmon M, Rickinson A, Akbar AN.

Blood. 2001 Feb 1;97(3):700-7.

12.

Programmed death-1 expression on HIV-1-specific CD8+ T cells is shaped by epitope specificity, T-cell receptor clonotype usage and antigen load.

Kløverpris HN, McGregor R, McLaren JE, Ladell K, Stryhn A, Koofhethile C, Brener J, Chen F, Riddell L, Graziano L, Klenerman P, Leslie A, Buus S, Price DA, Goulder P.

AIDS. 2014 Sep 10;28(14):2007-21.

13.

Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer.

Matsuzaki J, Gnjatic S, Mhawech-Fauceglia P, Beck A, Miller A, Tsuji T, Eppolito C, Qian F, Lele S, Shrikant P, Old LJ, Odunsi K.

Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7875-80. doi: 10.1073/pnas.1003345107.

14.

Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.

Sfanos KS, Bruno TC, Meeker AK, De Marzo AM, Isaacs WB, Drake CG.

Prostate. 2009 Nov 1;69(15):1694-703. doi: 10.1002/pros.21020.

15.

PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients.

Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z.

Mol Immunol. 2008 Feb;45(4):963-70.

PMID:
17868872
16.

Tonsillar homing of Epstein-Barr virus-specific CD8+ T cells and the virus-host balance.

Hislop AD, Kuo M, Drake-Lee AB, Akbar AN, Bergler W, Hammerschmitt N, Khan N, Palendira U, Leese AM, Timms JM, Bell AI, Buckley CD, Rickinson AB.

J Clin Invest. 2005 Sep;115(9):2546-55.

17.

Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Catalina MD, Sullivan JL, Brody RM, Luzuriaga K.

J Immunol. 2002 Apr 15;168(8):4184-91.

18.

Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling.

Radziewicz H, Ibegbu CC, Hon H, Bédard N, Bruneau J, Workowski KA, Knechtle SJ, Kirk AD, Larsen CP, Shoukry NH, Grakoui A.

J Immunol. 2010 Mar 1;184(5):2410-22. doi: 10.4049/jimmunol.0902994.

19.
20.

Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Blackburn SD, Crawford A, Shin H, Polley A, Freeman GJ, Wherry EJ.

J Virol. 2010 Feb;84(4):2078-89. doi: 10.1128/JVI.01579-09.

Items per page

Supplemental Content

Support Center